Romania

News from aidsmap

• Tipranavir study halted in treatment-naive

  Starting treatment
  Keith Alcorn | 21 June 2006

  Boehringer-Ingelheim has halted a three-year study of its new protease inhibitor tipranavir (Aptivus) in treatment-naïve patients because tipranavir-treated patients receiving a dose of 500mg with 100mg of ritonavir were found ...

• Bristol Myers Squibb to cut price of two HIV drugs for children

  HIV treatment
  Keith Alcorn | 28 June 2005

  Bristol Myers Squibb announced yesterday that is is cutting the cost of its paediatric formulations of two drugs – stavudine (Zerit) and didanosine (Videx) – in least developed countries. The cost ...

• Drug prices: updated international comparisons

  Keith Alcorn | 07 May 2002

  This is an updated version of a survey first published in April 2001, covering offers by pharmaceutical companies and generic manufacturers of discounted prices for antiretroviral drugs. To print this table, ...

• Drug access table: June 2001 update

  Keith Alcorn | 20 June 2001

  This table updates an edition published in April to include new data on prices and discounts offered by several Indian manufacturers of generic antiretrovirals, with the brand names of their ...

• Global drug prices: what is on offer today?

  Keith Alcorn | 20 April 2001

  This table summarises the latest information provided by companies regarding the prices at which they are currently offering antiretrovirals to resource-poor countries, and the terms of the offers. Some of these ...